Patricia R. Houck, MSH: An Intent-to-Treat Method for Enhancing Analysis of Clinical Trials with Rescue Medication: A Mixed-Model Approach

Name: Patricia R. Houck, MSH: An Intent-to-Treat Method for Enhancing Analysis of Clinical Trials with Rescue Medication: A Mixed-Model Approach
SKU: 3028
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 37 No. 1 Articles Tags: benoit-h-mulsant, bruce-g-pollock, charles-f-reynolds-iii, depression, intent-to-treat, mary-amanda-dew, medworks-media, mixed-effect, patricia-r-houck, psychopharmacology-bulletin, randomized-clinical-trial, rescue-treatment, sati-mazumdar

Description

Patricia R. Houck, MSH: An Intent-to-Treat Method for Enhancing Analysis of Clinical Trials with Rescue Medication: A Mixed-Model Approach

Description

Patricia R. Houck, MSH

GENERAL PSYCHOPHARMACOLOGY

An Intent-to-Treat Method for Enhancing Analysis of Clinical Trials with Rescue Medication: A Mixed-Model Approach

Patricia R. Houck, MSH, Sati Mazumdar, PhD, Benoit H. Mulsant, MD, Bruce G. Pollock, MD, PhD, Mary Amanda Dew, PhD, and Charles F. Reynolds III, MD

Antipsychotic Induced Symptomatic Hyperprolactinemia

Quetiapine XR Negative Clinical Trials Report by Gang Wang

Paliperidone Double-blind, Placebo- and Active-Controlled, Study

Schizophrenia Rating Scales Critical Review by Takefumi Suzuki

Patricia R. Houck, MSH: An Intent-to-Treat Method for Enhancing Analysis of Clinical Trials with Rescue Medication: A Mixed-Model Approach

Description

Patricia R. Houck, MSH

GENERAL PSYCHOPHARMACOLOGY

An Intent-to-Treat Method for Enhancing Analysis of Clinical Trials with Rescue Medication: A Mixed-Model Approach

Patricia R. Houck, MSH, Sati Mazumdar, PhD, Benoit H. Mulsant, MD, Bruce G. Pollock, MD, PhD, Mary Amanda Dew, PhD, and Charles F. Reynolds III, MD

Related products

Antipsychotic Induced Symptomatic Hyperprolactinemia

Quetiapine XR Negative Clinical Trials Report by Gang Wang

Paliperidone Double-blind, Placebo- and Active-Controlled, Study

Schizophrenia Rating Scales Critical Review by Takefumi Suzuki